Growth, Tolerance and Safety of an Extensively Hydrolysed Formula containing Two Human Milk Oligosaccharides in Infants with Cows’ Milk Protein Allergy

Objectives: To assess if an extensively hydrolysed formula (EHF) supplemented with 2 human milk oligosaccharides (HMO) supports normal growth and is well tolerated in infants with cow’s milk protein allergy (CMA). Methods: Infants aged 0-6 mo with CMAA were recruited at 44 sites to participate in a randomized clinical trial. Test formula was a whey-based EHF with 2’fucosyl-lactose (...

This article's user rating is

Want to find out more?

OR LOGIN IF YOU ARE ALREADY REGISTERED